Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-10-30

FDA Approved: VALACYCLOVIR HYDROCHLORIDE — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Valacyclovir hydrochloride submitted by Jubilant Cadista Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Valacyclovir hydrochloride (valacyclovir hydrochloride)

Snippet

SUPPL AP for VALACYCLOVIR HYDROCHLORIDE (VALACYCLOVIR HYDROCHLORIDE)